Senzime: Interview with Redeye Analyst Gustaf Meyer
Igår, 07:15
Igår, 07:15
Redeye recently initiated coverage of Senzime, a Swedish medtech company, specialising in quantitative neuromuscular patient monitoring with its flagship device, the TetraGraph system. We interviewed analyst Gustaf Meyer, who talked us through the investment case.
Igår, 07:15
Redeye recently initiated coverage of Senzime, a Swedish medtech company, specialising in quantitative neuromuscular patient monitoring with its flagship device, the TetraGraph system. We interviewed analyst Gustaf Meyer, who talked us through the investment case.
Fonder
Analyser
Aktierekommendationer
Aktiemarknaden
Fonder
Analyser
Aktierekommendationer
Aktiemarknaden
1 DAG %
Senast
OMX Stockholm 30
1 DAG %
Senast
2 637,44